Search

Search bills, members, committees and pages...

S. 3729

U.S. SenateIn Senate Committee

Summary

S. 3729, the PBM Reporting Transparency Act, was introduced in the Senate on Jan 29, 2026 by Sen. Mark Warner (D) with 3 co-sponsors. It was referred to Finance, and last saw action on Jan 29, 2026: Read twice and referred to the Committee on Finance.


Record

Text

S. 3729 has 3 co-sponsors.

sb3729/introduced-in-senate.txt
119 S3729 IS: PBM Reporting Transparency Act
U.S. Senate
2026-01-29
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
II 119th CONGRESS 2d Session S. 3729 IN THE SENATE OF THE UNITED STATES January 29, 2026 Mr. Warner (for himself, Mr. Tillis , Ms. Cortez Masto , and Mr. Marshall ) introduced the following bill; which was read twice and referred to the Committee on Finance A BILL
To require the Medicare Payment Advisory Commission (MedPAC) submit to Congress two reports on agreements with pharmacy benefit managers with respect to prescription drug plans and MA–PD plans.
1.
Short title
This Act may be cited as the PBM Reporting Transparency Act .
2.
MedPAC reports on agreements with pharmacy benefit managers with respect to prescription drug plans and MA–PD plans
The Medicare Payment Advisory Commission shall submit to Congress the following reports:
(1)
Initial report
Not later than the first March 15 occurring after the date that is 2 years after the date on which the Secretary makes the data available to the Commission, a report regarding agreements with pharmacy benefit managers with respect to prescription drug plans and MA–PD plans. Such report shall include, to the extent practicable—
(A)
a description of trends and patterns, including relevant averages, totals, and other figures for the types of information submitted;
(B)
an analysis of any differences in agreements and their effects on plan enrollee out-of-pocket spending and average pharmacy reimbursement, and other impacts; and
(C)
any recommendations the Commission determines appropriate.
(2)
Final report
Not later than 2 years after the date on which the Commission submits the initial report under paragraph (1), a report describing any changes with respect to the information described in paragraph (1) over time, together with any recommendations the Commission determines appropriate.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2026-01-29
  2. Passed Senate
  3. Passed House
  4. Conference
  5. To President
  6. Became Law

A bill to require the Medicare Payment Advisory Commission (MedPAC) submit to Congress two reports on agreements with pharmacy benefit managers with respect to prescription drug plans and MA-PD plans.

Sponsors

Sen. Mark Warner (D) sponsors S. 3729, and 3 members have co-sponsored it, all of them from the day it was introduced.

Committees

S. 3729 went before 1 committee: Finance.

Finance
Finance
Referred To · Jan 29, 2026 · 902 Bills

Actions

S. 3729 has taken 2 actions since Jan 29, 2026.

ChamberAction
Jan 29, 2026
Senate
Read twice and referred to the Committee on Finance.Finance Committee
Jan 29, 2026
Introduced in Senate

Votes

S. 3729 has not gone to a roll call.

Titles

S. 3729 goes by 3 titles, 1 of them short titles.

  • PBM Reporting Transparency Act — Display Title
  • PBM Reporting Transparency Act — Short Title(s) as Introduced
  • A bill to require the Medicare Payment Advisory Commission (MedPAC) submit to Congress two reports on agreements with pharmacy benefit managers with respect to prescription drug plans and MA-PD plans. — Official Title as Introduced

Lobbying

1 client hired 1 firm and 15 registered lobbyists who named S. 3729 in 2 quarterly filings, 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Health Issues, Insurance, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)District of Columbia12

Firms

Registrants who filed on the bill, by filings.

RegistrantClientsFilingsReported
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)12

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)2026 first_quarter$5.3M1st Quarter - Report
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)2026 second_quarter$3M2nd Quarter - Report

Classification

The Congressional Research Service files S. 3729 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; S. 3729’s is Health.

s3729/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Source: congress.gov · legiscan.com